193 related articles for article (PubMed ID: 15032090)
21. Autoimmune lymphoproliferative syndrome (ALPS) caused by Fas (CD95) mutation mimicking sarcoidosis.
Müllauer L; Emhofer J; Wohlfart S; Pichlhöfer B; Stary S; Ebetsberger G; Mannhalter C; Chott A
Am J Surg Pathol; 2008 Feb; 32(2):329-34. PubMed ID: 18223337
[TBL] [Abstract][Full Text] [Related]
22. A genetic disorder of lymphocyte apoptosis involving the fas pathway: the autoimmune lymphoproliferative syndrome.
Fleisher TA; Straus SE; Bleesing JJ
Curr Allergy Asthma Rep; 2001 Nov; 1(6):534-40. PubMed ID: 11895618
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune lymphoproliferative syndrome in a patient with common variable immunodeficiency: dichotomy of apoptosis.
Narra MB; Abdou NI
Ann Allergy Asthma Immunol; 2007 Jun; 98(6):585-8. PubMed ID: 17601274
[TBL] [Abstract][Full Text] [Related]
24. [The role of CD95 (APO-1/Fas) mutations in lymphoproliferative and malignant lymphatic diseases].
Beltinger C; Böhler T; Schrappe M; Ludwig WD; Debatin KM
Klin Padiatr; 1998; 210(4):153-8. PubMed ID: 9743945
[TBL] [Abstract][Full Text] [Related]
25. Autoimmune lymphoproliferative syndrome: a syndrome associated with inherited genetic defects that impair lymphocytic apoptosis--CT and US features.
Avila NA; Dwyer AJ; Dale JK; Lopatin UA; Sneller MC; Jaffe ES; Puck JM; Straus SE
Radiology; 1999 Jul; 212(1):257-63. PubMed ID: 10405750
[TBL] [Abstract][Full Text] [Related]
26. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
Straus SE; Jaffe ES; Puck JM; Dale JK; Elkon KB; Rösen-Wolff A; Peters AM; Sneller MC; Hallahan CW; Wang J; Fischer RE; Jackson CE; Lin AY; Bäumler C; Siegert E; Marx A; Vaishnaw AK; Grodzicky T; Fleisher TA; Lenardo MJ
Blood; 2001 Jul; 98(1):194-200. PubMed ID: 11418480
[TBL] [Abstract][Full Text] [Related]
27. The autoimmune lymphoproliferative syndrome (Canale-Smith) in adulthood.
Deutsch M; Tsopanou E; Dourakis SP
Clin Rheumatol; 2004 Feb; 23(1):43-4. PubMed ID: 14749982
[TBL] [Abstract][Full Text] [Related]
28. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.
Wang J; Zheng L; Lobito A; Chan FK; Dale J; Sneller M; Yao X; Puck JM; Straus SE; Lenardo MJ
Cell; 1999 Jul; 98(1):47-58. PubMed ID: 10412980
[TBL] [Abstract][Full Text] [Related]
29. Reversible monoclonal lymphadenopathy in autoimmune lymphoproliferative syndrome with functional FAS (CD95/APO-1) deficiency.
Ströbel P; Nanan R; Gattenlöhner S; Müller-Deubert S; Müller-Hermelink HK; Kreth HW; Marx A
Am J Surg Pathol; 1999 Jul; 23(7):829-37. PubMed ID: 10403307
[TBL] [Abstract][Full Text] [Related]
30. Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.
Bi LL; Pan G; Atkinson TP; Zheng L; Dale JK; Makris C; Reddy V; McDonald JM; Siegel RM; Puck JM; Lenardo MJ; Straus SE
BMC Med Genet; 2007 Jul; 8():41. PubMed ID: 17605793
[TBL] [Abstract][Full Text] [Related]
31. The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis.
Infante AJ; Britton HA; DeNapoli T; Middelton LA; Lenardo MJ; Jackson CE; Wang J; Fleisher T; Straus SE; Puck JM
J Pediatr; 1998 Nov; 133(5):629-33. PubMed ID: 9821419
[TBL] [Abstract][Full Text] [Related]
32. NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
Oliveira JB; Bidère N; Niemela JE; Zheng L; Sakai K; Nix CP; Danner RL; Barb J; Munson PJ; Puck JM; Dale J; Straus SE; Fleisher TA; Lenardo MJ
Proc Natl Acad Sci U S A; 2007 May; 104(21):8953-8. PubMed ID: 17517660
[TBL] [Abstract][Full Text] [Related]
33. [Autoimmune lymphoproliferative syndrome: an inherited or a somatic defect of apoptosis].
Rieux-Laucat F
Med Sci (Paris); 2006; 22(6-7):645-50. PubMed ID: 16828042
[TBL] [Abstract][Full Text] [Related]
34. Pathological findings in human autoimmune lymphoproliferative syndrome.
Lim MS; Straus SE; Dale JK; Fleisher TA; Stetler-Stevenson M; Strober W; Sneller MC; Puck JM; Lenardo MJ; Elenitoba-Johnson KS; Lin AY; Raffeld M; Jaffe ES
Am J Pathol; 1998 Nov; 153(5):1541-50. PubMed ID: 9811346
[TBL] [Abstract][Full Text] [Related]
35. Investigation of suspected deficient Fas-mediated apoptosis in a father and son.
Hanlon MG; Gacis ML; Kakakios AM; Kilham H
Cytometry; 2001 Mar; 43(3):195-8. PubMed ID: 11170106
[TBL] [Abstract][Full Text] [Related]
36. Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome.
Shenoy S; Arnold S; Chatila T
J Pediatr; 2000 May; 136(5):682-7. PubMed ID: 10802504
[TBL] [Abstract][Full Text] [Related]
37. Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival.
Bleesing JJ; Straus SE; Fleisher TA
Pediatr Clin North Am; 2000 Dec; 47(6):1291-310. PubMed ID: 11130997
[TBL] [Abstract][Full Text] [Related]
38. Inherited and acquired death receptor defects in human Autoimmune Lymphoproliferative Syndrome.
Rieux-Laucat F
Curr Dir Autoimmun; 2006; 9():18-36. PubMed ID: 16394653
[TBL] [Abstract][Full Text] [Related]
39. Impaired apoptosis of lymphocytes derived from patient with decreased expression of caspase-8 results in Alps-like phenotype.
Grzela T; Krauze A; Grzela K; Lazarczyk M; Niderla J; Brawura-Biskupski-Samaha R; Dziunycz P; Milewski L; Korczak-Kowalska G; Kulus M
Int J Mol Med; 2004 Nov; 14(5):937-42. PubMed ID: 15492869
[TBL] [Abstract][Full Text] [Related]
40. Molecular genetic studies in lymphocyte apoptosis and human autoimmunity.
Martin DA; Combadiere B; Hornung F; Jiang D; McFarland H; Siegel R; Trageser C; Wang J; Zheng L; Lenardo MJ
Novartis Found Symp; 1998; 215():73-82; discussion 82-91. PubMed ID: 9760572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
